We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+15.14%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$1.17B
AUM Growth
+$533M
Cap. Flow
+$384M
Cap. Flow %
32.78%
Top 10 Hldgs %
95.04%
Holding
22
New
4
Increased
3
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$727M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$47.3M
3
PLRX icon
Pliant Therapeutics
PLRX
+$14.9M
4
GBIO
Generation Bio
GBIO
+$11.3M
5
UBER icon
Uber
UBER
+$9.59M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$234M
2
PANW icon
Palo Alto Networks
PANW
+$177M
3
PING
Ping Identity Holding Corp.
PING
+$8.11M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$2.86M
5
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$1.33M

Sector Composition

Rank Sector Weight
1 Healthcare 67.47%
2 Technology 14.96%
3 Communication Services 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$26.1B
$713M 60.83%
+14,690,780
New +$727M
UBER icon
2
Uber
UBER
$134B
$96.7M 8.25%
3,112,186
+307,569
+11% +$9.59M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.91T
$89.5M 7.64%
1,262,960
+701,580
+125% +$47.3M
PANW icon
4
Palo Alto Networks
PANW
$264B
$78.7M 6.71%
2,055,672
-5,036,226
-71% -$177M
META icon
5
Meta Platforms (Facebook)
META
$1.51T
$38.6M 3.29%
169,783
-1,121,759
-87% -$234M
GLD icon
6
SPDR Gold Trust
GLD
$131B
$22.2M 1.89%
132,372
-6,575
-5% -$1.06M
RVMD icon
7
Revolution Medicines
RVMD
$40.2B
$21.2M 1.81%
670,382
– –
IVV icon
8
iShares Core S&P 500 ETF
IVV
$876B
$19.7M 1.68%
63,763
-9,743
-13% -$2.86M
PLRX icon
9
Pliant Therapeutics
PLRX
$67.5M
$18.3M 1.56%
+562,379
New +$14.9M
QQQ icon
10
Invesco QQQ Trust
QQQ
$455B
$16.3M 1.39%
65,673
+1,382
+2% +$310K
NCNA
11
NuCana
NCNA
$5.37M
$15.6M 1.33%
578
-4
-0.7% -$115K
GBIO
12
DELISTED
Generation Bio
GBIO
$10.6M 0.91%
+50,627
New +$11.3M
VEA icon
13
Vanguard FTSE Developed Markets ETF
VEA
$226B
$9.03M 0.77%
232,738
-28,653
-11% -$1.05M
FULC icon
14
Fulcrum Therapeutics
FULC
$248M
$7.51M 0.64%
410,714
– –
IJH icon
15
iShares Core S&P Mid-Cap ETF
IJH
$123B
$3.96M 0.34%
111,330
-16,120
-13% -$535K
IJR icon
16
iShares Core S&P Small-Cap ETF
IJR
$109B
$3.62M 0.31%
52,998
-5,993
-10% -$378K
VWO icon
17
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$3.1M 0.26%
78,199
-11,936
-13% -$442K
DNTH icon
18
Dianthus Therapeutics
DNTH
$5.68B
$2.5M 0.21%
20,788
– –
BNTX icon
19
BioNTech
BNTX
$22.6B
$2.13M 0.18%
+31,869
New +$1.59M
VIG icon
20
Vanguard Dividend Appreciation ETF
VIG
$111B
– –
-2,858
Closed -$295K
PING
21
DELISTED
Ping Identity Holding Corp.
PING
– –
-405,086
Closed -$8.11M
NTGN
22
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
– –
-505,871
Closed -$1.33M

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
DE
Diversified Enterprises Wilmington, Delaware $1.83B AUM 16.79% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Harvard Management Company's Q2 2020 Portfolio in Review

As of Q2 2020, Harvard Management Company held 22 positions worth $1.17B, up 83% from $639M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Harvard Management Company deployed $384M of net new capital in Q2 2020, opening 4 new positions and adding to 3 existing holdings. Its largest new stake was Royalty Pharma: 14,690,780 shares worth $713M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 6.3% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $234M trimmed.

  • Harvard Management Company's largest Q2 2020 buy was Royalty Pharma: 14,690,780 shares worth $713M.
  • Harvard Management Company added most to Alphabet (Google) Class A in Q2 2020, an estimated $47.3M increase.
  • Harvard Management Company's biggest Q2 2020 reduction was Meta Platforms (Facebook), cutting an estimated $234M.
  • Harvard Management Company fully exited Ping Identity Holding Corp. in Q2 2020, selling an estimated $8.11M.
  • Harvard Management Company's ten largest holdings make up 95% of its $1.17B portfolio in Q2 2020.
  • Harvard Management Company opened 4 new positions and closed 3 in Q2 2020.
  • Harvard Management Company's portfolio value rose 83% quarter-over-quarter to $1.17B.

Based on Harvard Management Company's 13F filing for Q2 2020, filed 14 Aug 2020.